Budesonide
NDC 0093-6817, Budesonide, suspension, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-6817
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- SUSPENSION
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204548
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-6817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE1 mg/2mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-6817-73 | 00093681773 | 6 POUCH in 1 CARTON (0093-6817-73) / 5 AMPULE in 1 POUCH (0093-6817-45) / 2 mL in 1 AMPULE (0093-6817-19) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d90ffda1-12c7-4726-90e9-64bb103e84b5Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0093-6817NADAC price for package 00093681773
GET /v1/drugs/nadac/00093681773
Use it
Look up 0093-6817 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-6817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-6817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.